Jointown Pharmaceutical Group Co (SHSE:600998) Debt-to-Equity : 0.57 (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Jointown Pharmaceutical Group Co Debt-to-Equity?

Jointown Pharmaceutical Group Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥14,199 Mil. Jointown Pharmaceutical Group Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥1,937 Mil. Jointown Pharmaceutical Group Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥28,230 Mil. Jointown Pharmaceutical Group Co's debt to equity for the quarter that ended in Mar. 2025 was 0.57.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Jointown Pharmaceutical Group Co's Debt-to-Equity or its related term are showing as below:

SHSE:600998' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.46 Med: 0.7 Max: 1.18
Current: 0.57

During the past 13 years, the highest Debt-to-Equity Ratio of Jointown Pharmaceutical Group Co was 1.18. The lowest was 0.46. And the median was 0.70.

SHSE:600998's Debt-to-Equity is ranked worse than
65.26% of 95 companies
in the Medical Distribution industry
Industry Median: 0.39 vs SHSE:600998: 0.57

Jointown Pharmaceutical Group Co Debt-to-Equity Historical Data

The historical data trend for Jointown Pharmaceutical Group Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jointown Pharmaceutical Group Co Debt-to-Equity Chart

Jointown Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.82

0.73

0.62

0.49

Jointown Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Debt-to-Equity	Get a 7-Day Free Trial															0.66	0.71	0.54	0.49	0.57

Competitive Comparison of Jointown Pharmaceutical Group Co's Debt-to-Equity

For the Medical Distribution subindustry, Jointown Pharmaceutical Group Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jointown Pharmaceutical Group Co's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Jointown Pharmaceutical Group Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Jointown Pharmaceutical Group Co's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Jointown Pharmaceutical Group Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Jointown Pharmaceutical Group Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11511.946	+	1716.888)	/	27243.192
	=	0.49

Jointown Pharmaceutical Group Co's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(14198.935	+	1936.52)	/	28229.696
	=	0.57

Jointown Pharmaceutical Group Co (SHSE:600998) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Jointown Pharmaceutical Group Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Jointown Pharmaceutical Group Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Jointown Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Jointown Pharmaceutical Group Co Ltd (SHSE:600998) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5, Longxing West Street, Hanyang District, Hubei Province, Wuhan, CHN, 430051

Website

http://www.jztey.com

Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and primarily serves medical institutions, wholesale enterprises, and retail pharmacies.

Executives

Wang Qi Bing	senior management
He Wei	Directors, senior managers
Zhang Qing Song	senior management
Yang Nie	senior management
Liu Zhao Nian	Director
Xu Ying Zheng	Supervisors
Guo Lei	senior management
Ai Hua	Director
Gong Yi Hua	Directors, senior managers
Lin Xin Yang	Directors, senior managers
Yang Ju Mei	senior management
Liu Yi Chang	Director
Chen Qi Ming	Directors, senior managers
Chen Li	Supervisors
Liu Su Fang	senior management

Jointown Pharmaceutical Group Co Headlines

No Headlines